Viewing Study NCT02429518


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-02-20 @ 5:57 PM
Study NCT ID: NCT02429518
Status: COMPLETED
Last Update Posted: 2020-09-04
First Post: 2015-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Sponsor: Knight Therapeutics (USA) Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module